Mink Therapeutics Stock Buy Hold or Sell Recommendation

INKT Stock  USD 8.49  0.51  6.39%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Mink Therapeutics is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Mink Therapeutics given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Mink Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Mink Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.
Note, we conduct extensive research on individual companies such as Mink and provide practical buy, sell, or hold advice based on investors' constraints. Mink Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

Execute Mink Therapeutics Buy or Sell Advice

The Mink recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Mink Therapeutics. Macroaxis does not own or have any residual interests in Mink Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Mink Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Mink TherapeuticsBuy Mink Therapeutics
Strong Sell

Market Performance

OKDetails

Volatility

Very riskyDetails

Hype Condition

Over hypedDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

HighDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Investor Sentiment

InterestedDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Mink Therapeutics has a Mean Deviation of 7.59, Semi Deviation of 9.05, Standard Deviation of 12.46, Variance of 155.24, Downside Variance of 102.85 and Semi Variance of 81.82
We provide investment recommendation to complement the last-minute expert consensus on Mink Therapeutics. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Mink Therapeutics is not overpriced, please verify all Mink Therapeutics fundamentals, including its cash flow from operations, and the relationship between the cash and equivalents and beta . Given that Mink Therapeutics has a number of shares shorted of 30.68 K, we recommend you to check Mink Therapeutics market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Mink Therapeutics Trading Alerts and Improvement Suggestions

Mink Therapeutics is way too risky over 90 days horizon
Mink Therapeutics appears to be risky and price may revert if volatility continues
Mink Therapeutics has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (22.46 M) with profit before overhead, payroll, taxes, and interest of 0.
Mink Therapeutics currently holds about 29.85 M in cash with (15.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.88.
Mink Therapeutics has a poor financial position based on the latest SEC disclosures
Roughly 75.0% of the company shares are held by company insiders
Latest headline from news.google.com: MiNK Therapeutics Projected to Post Earnings on Tuesday - Defense World

Mink Therapeutics Returns Distribution Density

The distribution of Mink Therapeutics' historical returns is an attempt to chart the uncertainty of Mink Therapeutics' future price movements. The chart of the probability distribution of Mink Therapeutics daily returns describes the distribution of returns around its average expected value. We use Mink Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Mink Therapeutics returns is essential to provide solid investment advice for Mink Therapeutics.
Mean Return
1.05
Value At Risk
-14.1
Potential Upside
19.78
Standard Deviation
12.46
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Mink Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Mink Stock Institutional Investors

The Mink Therapeutics' institutional investors refer to entities that pool money to purchase Mink Therapeutics' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
Shares
Tower Research Capital Llc2024-09-30
K
Bank Of America Corp2024-09-30
K
Advisor Group Holdings, Inc.2024-09-30
1.4 K
Covestor Ltd2024-09-30
K
Morgan Stanley - Brokerage Accounts2024-09-30
336
Jpmorgan Chase & Co2024-09-30
258
Northwestern Mutual Wealth Management Co2024-09-30
190
Game Plan Financial Advisors, Llc2024-09-30
170
Key Financial, Inc.2024-09-30
43.0
Vanguard Group Inc2024-09-30
234.2 K
Longbow Finance Sa2024-09-30
166.7 K
Note, although Mink Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Mink Therapeutics Cash Flow Accounts

202020212022202320242025 (projected)
Investments(95.2K)(249.0K)(250.0K)(201.4K)(231.6K)(243.2K)
Change In Cash2.4M36.2M(19.3M)(16.3M)(14.6M)(13.9M)
Free Cash Flow(8.4M)(13.1M)(19.1M)(15.8M)(14.3M)(15.0M)
Depreciation55.1K78.0K121.7K204.6K235.3K247.1K
Other Non Cash Items8.1M12.2M(2.8M)(266.8K)(240.1K)(228.1K)
Capital Expenditures95.2K249.0K250.0K73.6K66.2K62.9K
Net Income(16.2M)(30.2M)(28.0M)(22.5M)(20.2M)(21.2M)
End Period Cash Flow2.7M38.9M19.6M3.4M3.9M3.7M

Mink Therapeutics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Mink Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Mink Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Mink stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
1.08
β
Beta against Dow Jones0.37
σ
Overall volatility
12.90
Ir
Information ratio 0.09

Mink Therapeutics Volatility Alert

Mink Therapeutics is showing large volatility of returns over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Mink Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Mink Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Mink Therapeutics Fundamentals Vs Peers

Comparing Mink Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Mink Therapeutics' direct or indirect competition across all of the common fundamentals between Mink Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Mink Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Mink Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Mink Therapeutics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Mink Therapeutics to competition
FundamentalsMink TherapeuticsPeer Average
Return On Equity-12.39-0.31
Return On Asset-1.2-0.14
Current Valuation29.91 M16.62 B
Shares Outstanding3.96 M571.82 M
Shares Owned By Insiders74.83 %10.09 %
Shares Owned By Institutions2.09 %39.21 %
Number Of Shares Shorted30.68 K4.71 M
Price To Book10.05 X9.51 X
EBITDA(22.25 M)3.9 B
Net Income(22.46 M)570.98 M
Cash And Equivalents29.85 M2.7 B
Cash Per Share0.88 X5.01 X
Total Debt22.61 M5.32 B
Current Ratio1.74 X2.16 X
Book Value Per Share(4.44) X1.93 K
Cash Flow From Operations(15.76 M)971.22 M
Short Ratio0.43 X4.00 X
Earnings Per Share(3.70) X3.12 X
Target Price48.33
Number Of Employees3118.84 K
Beta0.16-0.15
Market Capitalization33.64 M19.03 B
Total Asset4.55 M29.47 B
Retained Earnings(133.4 M)9.33 B
Working Capital(7.8 M)1.48 B
Net Asset4.55 M
Note: Acquisition by Corvese Brian of 2033 shares of Mink Therapeutics at 8.79 subject to Rule 16b-3 [view details]

Mink Therapeutics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Mink . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Mink Therapeutics Buy or Sell Advice

When is the right time to buy or sell Mink Therapeutics? Buying financial instruments such as Mink Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Mink Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cigarettes Thematic Idea Now

Cigarettes
Cigarettes Theme
Tobacco makers and distributors across globe. The Cigarettes theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cigarettes Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Mink Stock Analysis

When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.